Director, International Policy Analytics

Working with Us
Challenging. Meaningful. Life-changing. Those aren’t words that are usually associated with a job. But working at Bristol Myers Squibb is anything but usual. Here, uniquely interesting work happens every day, in every department. From optimizing a production line to the latest breakthroughs in cell therapy, this is work that transforms the lives of patients, and the careers of those who do it. You’ll get the chance to grow and thrive through opportunities uncommon in scale and scope, alongside high-achieving teams. Take your career farther than you thought possible.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives. Read more: careers.bms.com/working-with-us.

Position Summary

The Director, International Policy Analytics will lead analytical assessments of ex U.S. pharmaceutical policy and pricing reforms, translating complex international policy developments into decision‑ready insights that inform enterprise strategy, policy research evidence generation, and external policy engagement. This role will focus on evaluating the impact of policies related to government pricing, reimbursement, and trade policies across priority international markets, including Europe, Asia ‑Pacific, and other key geographies.

The individual will partner closely with the International Policy and Government Affairs team and other cross functional stakeholders to assess portfolio and enterprise implications of diverse policy frameworks—such as health technology assessment (HTA) reforms, external reference pricing, price controls, budget impact policies, managed entry agreements, and ‑trade related measures—and synthesize insights for senior leadership. This role plays a critical part in ensuring BMS leadership understands the global and cross market implications of international policy developments in a rapidly evolving environment.

Key Responsibilities

• Lead analytical assessments of international pharmaceutical policy reforms across priority ex U.S. markets, including pricing, reimbursement, access, HTA, and ‑trade related‑ policies.

• Develop, maintain, and apply analytical frameworks and models to assess the portfolio and enterprise impact of international government pricing and reimbursement policies.

• Monitor and interpret international statutes, regulations, policy guidance, and HTA processes, translating complex and market specific‑ policy developments into actionable insights.

• Support policy research evidence generation by producing robust analyses that inform international policy positions, evidence packages, and advocacy narratives.

• Partner with the international policy team to provide analytics that support external policy engagement with governments, regulators, HTA bodies, and other policy stakeholders.

• Assess cross market‑ and spillover effects of international policy reforms (e.g., reference pricing, trade dynamics, global affordability initiatives) and their implications for enterprise strategy.

• Prepare clear, executive ready‑ presentations and written materials that communicate analytical findings, uncertainties, and strategic tradeoffs to senior leadership.

• Collaborate cross-functionally ‑with Global Health Systems Analytics, Global Pricing, Global Market Access (MAx), Regional Market Access teams, Legal, HEOR, Finance, and Business Insights & Technology (BIT).

• Track emerging international policy trends and identify potential risks and opportunities, escalating insights and recommendations as appropriate.

• Leverage digital tools and AI e‑nabled analytics to enhance analytical rigor, efficiency, and scalability across international policy assessments.

• Provide guidance, prioritization, and quality oversight for international policy analytics deliverables.

• Mentor and develop team members and contribute to broader Global Policy Analytics capability‑building.

Qualifications

• Advanced degree preferred (e.g., MPH, MPP, MBA, PhD, PharmD, or equivalent).

• 7–10+ years of experience in international health policy, pricing, reimbursement, HTA, or policy analytics.

• Strong understanding of international pharmaceutical policy frameworks, including government pricing, reimbursement systems, HTA processes, and access policies.

• Experience analyzing cross‑ma